Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The KEMRI-Wellcome Research Programme (KWTRP) has announced the appointment of Professor Edwine Barasa as its new Director.

A respected health economist and long-standing member of KWTRP, Professor Barasa has served as Director of the Nairobi Programme and Head of the Health Economics Research Unit (HERU). His appointment marks a significant moment for the Programme and for research leadership across Kenya and throughout Africa.

In his new role, Professor Barasa will provide strategic leadership to KWTRP’s multidisciplinary research efforts, which span biosciences, clinical research, epidemiology and demography, and health systems and policy. He will work closely with colleagues across the Programme’s sites in Kilifi, Nairobi and beyond, as well as with national institutions, regional networks and international collaborators.

Professor Basara said: ‘I am excited about the journey ahead and thank the partners for their trust in me to steward the Programme. My commitment is to strengthen our impact as we continue to build a Programme that delivers outstanding science, shapes policy and practice, develops the next generation of African research leaders, and provides solutions to some of the most pressing health challenges of our time.’

Professor Barasa brings to the role over 15 years of experience in health systems research and policy engagement. He holds a PhD in Health Economics from the University of Cape Town and a Bachelor of Pharmacy from the University of Nairobi. His work has informed national health reforms in Kenya, and he continues to advise governments and regional bodies across sub-Saharan Africa.

Professor Richard Cornall, Head of the Nuffield Department of Medicine at the University of Oxford, said: ‘Edwine brings exceptional scientific rigour, policy insight, and an unwavering commitment to world-class basic and clinical research aimed at improving human health globally. His appointment further strengthens the long-standing collaboration between KWTRP, KEMRI, NDM Oxford, and Wellcome.’

KWTRP was established through a partnership between the Kenya Medical Research Institute (KEMRI), the Nuffield Department of Medicine University of Oxford, and Wellcome, and has grown into one of Africa’s leading health research programmes. With over 800 staff, it operates across multiple sites in Kenya, delivering research that informs health policy and improves health outcomes both locally and globally.

Similar stories

Leadership transition at Oxford Global Health

After two and a half years leading the Oxford Global Health initiative, Professor Alan Bernstein steps down, with new Co-Directors, Professors Susanna Dunachie and Caesar Atuire, appointed to guide its next phase.

Professor Nicholas Day Honoured for Services to Global Health

Professor Nicholas Day has been recognised for his outstanding contribution to global health research in the Kings New Years Honours 2026.

Medical Humanities receives 2025 Vice-Chancellor’s Award for Research Culture

The Oxford Centre for the Humanities,TORCH, Medical Humanities Research Hub (MedHum) has received the 2025 University of Oxford Vice-Chancellor’s Award for Research Culture.

Engaging stakeholders to build a Kenyan learning health system success in Vice-Chancellor’s Awards

Work led by a NDM Centre for Global Health Research (CGHR) and KEMRI-Wellcome team `Engaging stakeholders to build a Kenyan learning health system’ was recognised as winner of the Vice-Chancellor’s Research Engagement Award.

New Co-Associate Directors of Oxford Global Health

We are pleased to announce the appointment of Professor Susanna Dunachie and Dr Caesar Atuire as Co-Associate Directors of Oxford Global Health.

IOI awards £5m to Oxford consortium to develop new therapies for drug-resistant tuberculosis

The Ineos Oxford Institute for antimicrobial research (IOI) has awarded £5 million to a group of 17 interdisciplinary researchers from Oxford University to develop new therapies for drug-resistant tuberculosis.